Change in clinical presentation at admission in children with newly diagnosed type 1 diabetes during the COVID-19 pandemic in the eastern region of Turkey

Basit Öğe Kaydı
dc.contributor.authorDündar, İsmail
dc.contributor.authorAkıncı, Ayşehan
dc.contributor.authorÇamtosun, Emine
dc.contributor.authorÇiftçi, Nurdan
dc.contributor.authorKayaş, Leman
dc.date.accessioned2024-08-04T19:42:42Z
dc.date.available2024-08-04T19:42:42Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract Aim: The COVID-19 pandemic is a global health problem with high morbidity and mortality. This study aimed to compare the clinical features of newly diagnosed type 1 diabetes (T1D) patients during the pandemic with those diagnosed earlier and evaluate how the pandemic affected the T1D clinical findings on admission. Materials and Methods: This is a 2-year, single-center, cross-sectional study. The time between March 11, 2019, and March 11, 2020, was defined as the “pre-pandemic period,” while the interval between March 11, 2020, and March 11, 2021, was called the “pandemic period.” The clinical and laboratory parameters of newly diagnosed T1D patients admitted in these two time periods were compared. Results: The admission rate with DKA was higher in the pandemic period than in the pre-pandemic time (71.0% and 52.8%, respectively, p=0.046). There was no difference between the groups regarding the severity of DKA. The mean duration of diabetes symptoms before diagnosis was longer during the pandemic than in the pre-pandemic period (17.0 days and 12.5 days, respectively, p=0.035). Conclusion: Delayed admissions to health institutions of patients with diabetes signs and symptoms during the pandemic are worrisome. This delay is likely to have increased the DKA rate during the pandemic. As a result, children with diabetes symptoms should be ensured to apply to a health institution without hesitation, even in the pandemic.en_US
dc.identifier.doi10.5455/annalsmedres.2022.01.035
dc.identifier.endpage760en_US
dc.identifier.issn2636-7688
dc.identifier.issue7en_US
dc.identifier.startpage755en_US
dc.identifier.trdizinid1119459en_US
dc.identifier.urihttps://doi.org/10.5455/annalsmedres.2022.01.035
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1119459
dc.identifier.urihttps://hdl.handle.net/11616/88574
dc.identifier.volume29en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofAnnals of Medical Researchen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleChange in clinical presentation at admission in children with newly diagnosed type 1 diabetes during the COVID-19 pandemic in the eastern region of Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu